The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Open accessAbstract
Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationGalluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“However, inducers of TEI in microbial-rich versus “sterile” tumors may be different (Hanahan and Coussens, 2012; Mantovani et al., 2008).”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,001
Opportunities and challenges of targeting cGAS–STING in cancer
Lu, C., Wang, W., & Fu, Y. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00894-9 · Cited by 73
MUC1-C drives stemness in progression of colitis to colorectal cancer
Li, W., Zhang, N., Jin, C., Long, M. D., Rajabi, H. N., Yasumizu, Y., Fushimi, A., Yamashita, N., Hagiwara, M., Zheng, R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137112 · Cited by 65
Prabhu, K. S., Bhat, A. A., Siveen, K. S., Kuttikrishnan, S., Raza, S. S., Raheed, T., Jochebeth, A., Khan, A. Q., Chawdhery, M. Z., Haris, M., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112358 · Cited by 62
Jaén, M., Martín‐Regalado, Á., Bartolomé, R. A., Robles, J., & Casal, J. I. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188802 · Cited by 65
Metabolic Health, Mitochondrial Fitness, Physical Activity, and Cancer
Clemente‐Suárez, V. J., Martín-Rodríguez, A., Redondo-Flórez, L., Ruisoto, P., Navarro-Jiménez, E., Ramos‐Campo, D. J., & Tornero-Aguilera, J. F. (2023) · Cancers · doi:10.3390/cancers15030814 · Cited by 71
Rahmani, A. H., Almatroudi, A., Allemailem, K. S., Alwanian, W. M., Alharbi, B. F., Alrumaihi, F., Khan, A. A., & Almatroodi, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119665 · Cited by 67
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Fukuda, Y., Bustos, M. A., Cho, S.-N., Roszik, J., Ryu, S., López, V., Burks, J. K., Lee, J. E., Grimm, E. A., Hoon, D. S. �., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04552-y · Cited by 61
Post-Translational Modifications of STING: A Potential Therapeutic Target
Kang, J., Wu, J., Liu, Q., Wu, X., Zhao, Y., & Ren, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888147 · Cited by 62
Ren, W., Ban, J., Xia, Y., Zhou, F., Yuan, C., Jia, H., Huang, H., Jiang, M., Liang, M., Li, Z., et al. (2023) · The Innovation · doi:10.1016/j.xinn.2023.100391 · Cited by 62
Singh, R. P., Kumari, N., Gupta, S., Jaiswal, R., Mehrotra, D., Singh, S. K., Mukherjee, S., & Kumar, R. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04596-22 · Cited by 61
Teng, H., He, Z., Hong, C.-Z., Xie, S.-Z., & Zha, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117809 · Cited by 62
Araujo, A. M., Abaurrea, A., Azcoaga, P., López-Velazco, J. I., Manzano, S., Rodríguez, J., Rezola, R., Egia‐Mendikute, L., Valdés‐Mora, F., Flores, J. M., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148667 · Cited by 62
Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease
Wooddell, C. I., Blomenkamp, K., Peterson, R. M., Subbotin, V. M., Schwabe, C., Hamilton, J., Chu, Q., Christianson, D. R., Hegge, J., Kolbe, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135348 · Cited by 60
Zhao, Y. C., Cao, Y., Chen, Y., Wu, L., Hang, H., Jiang, C., & Zhou, X. (2021) · Immunology · doi:10.1111/imm.13384 · Cited by 58
Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 61
SIRT6 Widely Regulates Aging, Immunity, and Cancer
Li, Y., Jin, J., & Wang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.861334 · Cited by 61
Exosomes-mediated tumor metastasis through reshaping tumor microenvironment and distant niche
Luo, X., Li, Y., Hua, Z., Xue, X., Wang, X., Pang, M., Xiao, C., Zhao, H., Lü, A., & Liu, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.050 · Cited by 63
Inflammatory bowel disease, colitis, and cancer: unmasking the chronic inflammation link
Khaze, V., Noorolyai, S., Youshanlui, M. A., Hossein, S., Nasiri, H., Mansoori, B., Holmskov, U., & Baradaran, B. (2024) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04748-y · Cited by 69
Vasconcelos, A. G., Valim, M. O., Amorim, A. D. G. N., do Amaral, C. P., de Almeida, M. P., Borges, T. K. D. S., Socodato, R., Portugal, C. C., Brand, G. D., Mattos, J. S. D. C., et al. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109548 · Cited by 58
Becerril-Rico, J., Alvarado-Ortiz, E., Toledo-Guzmán, M. E., Pelayo, R., & Ortíz-Sánchez, E. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02562-9 · Cited by 58
Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression
Costa, P. A. C., da Silva, W. N., Prazeres, P. H. D. M., Picoli, C. C., Guardia, G. D. A., Costa, A. C., Oliveira, M. D. A., Guimarães, P. P. G., Gonçalves, R., Pinto, M. C. X., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01273-9 · Cited by 59
Pagadala, M. S., Sears, T. J., Wu, V. H., Pérez‐Guijarro, E., Kim, H., Castro, A., Talwar, J. V., González-Colín, C., Cao, S., Schmiedel, B. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38271-5 · Cited by 54
Puricelli, C., Gigliotti, C. L., Stoppa, I., Sacchetti, S., Pantham, D., Scomparin, A., Rolla, R., Pizzimenti, S., Dianzani, U., Boggio, E. M., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061772 · Cited by 62
Zhao, S., Zhang, X., Chen, S., & Zhang, S. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01700-0 · Cited by 59
Clinical perspectives on the age-related increase of immunosuppressive activity
Salminen, A. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02193-4 · Cited by 57
Therapeutic Exploitation of GPR18: Beyond the Cannabinoids?
Morales, P., Lago-Fernandez, A., Hurst, D. P., Sotudeh, N., Brailoiu, E., Reggio, P. H., Abood, M. E., & Jagerovic, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00926 · Cited by 57
Ban, Y., Markowitz, G. J., Zou, Y., Ramchandani, D., Kraynak, J., Sheng, J., Lee, S. B., Wong, S. T. C., Altorki, N. K., Gao, D., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00245-1 · Cited by 57
Wang, D., Jiang, S., Zhang, F., Ma, S., Heng, B. C., Wang, Y., Zhu, J., Xu, M., He, Y., Wei, Y. Q., et al. (2021) · Advanced Science · doi:10.1002/advs.202101562 · Cited by 56
The regulatory role of PDE4B in the progression of inflammatory function study
Su, Y., Ding, J., Yang, F., He, C., Xu, Y., Zhu, X., Zhou, H., & Li, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.982130 · Cited by 58
Wu, J., Chan, Y.-T., Lu, Y., Wang, N., & Feng, Y. (2023) · Medicinal Research Reviews · doi:10.1002/med.21967 · Cited by 56
C-Reactive Protein Signaling Pathways in Tumor Progression
Kim, E., Kim, S. Y., & Moon, A. (2023) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.132 · Cited by 58
Fumarate hydratase as a metabolic regulator of immunity
Peace, C. G., O’Carroll, S. M., & O'Neill, L. A. J. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.10.005 · Cited by 61
Simpson, E. L., Silverberg, J. I., Nosbaum, A., Winthrop, K. L., Guttman‐Yassky, E., Hoffmeister, K. M., Egeberg, A., Valdez, H., Fan, H., Farooqui, S. A., et al. (2024) · American Journal of Clinical Dermatology · doi:10.1007/s40257-024-00869-w · Cited by 57
PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations
Lin, J., Wang, T., Huang, R., Tan, Y., Chen, D., & Ju, H. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01329-z · Cited by 63
Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis
Liu, Z., Sun, Z., Liu, H., Niu, W., Wang, X., Liang, N., Wang, X., Wang, Y., Shi, Y., Xu, L., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00562-z · Cited by 57
Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
Baram, T., Rubinstein-Achiasaf, L., Ben-Yaakov, H., & Ben‐Baruch, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.614468 · Cited by 61
Ho, Y.-T., Shimbo, T., Wijaya, E., Kitayama, T., Takaki, S., Ikegami, K., Miyashita, K., Ouchi, Y., Takaki, E., Yamamoto, R., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.004 · Cited by 56
Capula, M., Perán, M., Xu, G., Donati, V. L., Yee, D., Gregori, A., Assaraf, Y. G., Giovannetti, E., & Deng, D. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100864 · Cited by 55
Balancing functional and health benefits of food products formulated with palm oil as oil sources
Sulaiman, N. S., Sintang, M. D. B., Mantihal, S., Zaini, H. M., Munsu, E., Mamat, H., Kanagaratnam, S., Jahurul, M. H. A., & Pindi, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11041 · Cited by 56
Madeddu, C., Busquets, S., Donisi, C., Lai, E., Pretta, A., López-Soriano, F. J., Argilés, J. M. A., Scartozzi, M., & Macciò, A. (2023) · Cancers · doi:10.3390/cancers15041076 · Cited by 60
Ryan, S. T., Beheshti, E. H., Afrose, D., Ding, X., Xia, B., Grau, G. E., Little, C. B., McClements, L., & Li, J. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063023 · Cited by 54
KDM6 Demethylases and Their Roles in Human Cancers
Hua, C., Chen, J., Li, S., Zhou, J., Fu, J., Sun, W., & Wang, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.779918 · Cited by 57
Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer
Pérez, P. E., Riquelme, I., García, P., Brebi, P., & Roa, J. C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020234 · Cited by 58
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
Chen, C., Zhou, Y., Ning, X., Li, S., Xue, D., Wei, C., Zhu, Z., Sheng, L., Lu, B., Li, Y., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02682-w · Cited by 59
Shi, T., Wang, J., Dong, J., Hu, P., & Guo, Q. (2023) · Pathogens · doi:10.3390/pathogens12091110 · Cited by 55
Gouda, N. A., Alshammari, S. O., Abourehab, M. A. S., Alshammari, Q. A., & Elkamhawy, A. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01366-y · Cited by 59
Zhou, H., Wang, L., Lin, Z., Jiang, C., Chen, X., Wang, K., Liu, L., Shao, L., Pan, J., Li, J., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007840 · Cited by 55
Sabit, H., Arneth, B. M., Pawlik, T. M., Abdel-Ghany, S. E., Ghazy, A., Abdelazeem, R. M., Alqosaibi, A. I., Al-Dhuayan, I. S., Almulhim, J., Alrabiah, N. A., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18010075 · Cited by 59
Bone marrow inflammation in haematological malignancies
de Jong, M. M. E., Chen, L., Raaijmakers, M. H. G. P., & Cupedo, T. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01003-x · Cited by 54
Creating and Validating a DNA Methylation-Based Proxy for Interleukin-6
Stevenson, A. J., Gadd, D. A., Hillary, R. F., McCartney, D. L., Campbell, A., Walker, R. M., Evans, K. L., Harris, S. E., Spires‐Jones, T. L., McRae, A. F., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab046 · Cited by 50
Vella, V., Lappano, R., Bonavita, E., Maggiolini, M., Clarke, R. B., Belfiore, A., & Francesco, E. M. D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad005 · Cited by 59
Inflammatory Networks in Renal Cell Carcinoma
Kruk, L., Mamtimin, M., Braun, A., Anders, H., Andrassy, J., Gudermann, T. W., & Mammadova‐Bach, E. (2023) · Cancers · doi:10.3390/cancers15082212 · Cited by 59
Interactions between diet and gut microbiota in cancer
Nakatsu, G., Andreeva, N., MacDonald, M. H., & Garrett, W. S. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01736-4 · Cited by 58
Microbe-material hybrids for therapeutic applications
Chen, M., Xia, L., Wu, C., Wang, Z., Ding, L. S., Xie, Y., Feng, W., & Chen, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00655g · Cited by 56
Human amniotic mesenchymal stem cells to promote/suppress cancer: two sides of the same coin
Jafari, A., Rezaei–Tavirani, M., Farhadihosseinabadi, B., Zali, H., & Niknejad, H. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02196-x · Cited by 54
Drug resistance mechanisms in cancers: Execution of pro-survival strategies
Dhanyamraju, P. K. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230248 · Cited by 56
Hyun, J., Abo, M. A., Dutta, R. K., Oh, S., Xiang, K., Zhou, X., Maeso‐Díaz, R., Caffrey, R., Sanyal, A. J., Freedman, J. A., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.033 · Cited by 53
Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence
Zhang, C., Xie, C., & Lu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.669746 · Cited by 53
Siltari, A., Syvälä, H., Lou, Y., Gao, Y., & Murtola, T. J. (2022) · Cancers · doi:10.3390/cancers14174293 · Cited by 53
Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Wang, G., He, X., & Wang, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188846 · Cited by 51
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
Xie, J., Zhang, J., Tian, W., Zou, Y., Tang, Y., Zheng, S., Wong, C., Deng, X., Wu, S., Chen, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415647 · Cited by 51
The role of myokines in cancer: crosstalk between skeletal muscle and tumor
Park, S.-Y., Hwang, B.-O., & Song, N. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0064 · Cited by 52
Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells
Rabas, N., Ferreira, R. M. M., Blasio, S. D., & Malanchi, I. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00752-0 · Cited by 58
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
Abdelmonem, B. H., Kamal, L. T., Wardy, L. W., Ragheb, M., Hanna, M. M., Elsharkawy, M., & Abdelnaser, A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1534862 · Cited by 55
Bakrim, S., Fessikh, M. E., Elhrech, H., Omari, N. E., Amanullah, M. R., Ming, L. C., Moshawih, S., & Bouyahya, A. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06583-3 · Cited by 58
Jeong, W., & Jho, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.714330 · Cited by 54
HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System
Cyran, A. M., & Zhitkovich, A. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00131 · Cited by 55
Bioresponsive Immunotherapeutic Materials
Han, J., Sheng, T., Zhang, Y., Cheng, H., Gao, J., Yu, J., & Gu, Z. (2023) · Advanced Materials · doi:10.1002/adma.202209778 · Cited by 52
Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes
Dutta, A., Bhagat, S., Paul, S., Katz, J. P., Sengupta, D., & Bhargava, D. K. (2023) · Vaccines · doi:10.3390/vaccines11061028 · Cited by 55
Inflammation and cancer: molecular mechanisms and clinical consequences
Akkız, H., Şimşek, H., Balcı, D., Ülger, Y., Onan, E., Ozturk, N. A., & Delik, A. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1564572 · Cited by 59
Barathan, M., & Hanafiah, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094264 · Cited by 56
Ding, Y., Hao, K., Li, Z., Ma, R., Zhou, Y. L., Zhou, Z., Wei, M., Liao, Y., Dai, Y., Yang, Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29317 · Cited by 52
In-depth analysis of lupeol: delving into the diverse pharmacological profile
Dalimunthe, A., Carensia Gunawan, M., Dhiya Utari, Z., Dinata, M. R., Halim, P., Estherina S. Pakpahan, N., Sitohang, A. I., Sukarno, M. A., Yuandani, Harahap, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1461478 · Cited by 50
Shabgah, A. G., Suksatan, W., Achmad, M. H., Bokov, D. O., Abdelbasset, W. K., Ezzatifar, F., Hemmati, S., Mohammadi, H., Soleimani, D., Jadidi‐Niaragh, F., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174419 · Cited by 51
Thyroid hormones act as modulators of inflammation through their nuclear receptors
Lasa, M., & Contreras‐Jurado, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.937099 · Cited by 56
Qadir, J., Wen, S.-Y., Yuan, H., & Yang, B. B. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.12.005 · Cited by 52
Li, Y., Sui, S., & Goel, A. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.02.001 · Cited by 51
Papait, A., Stefani, F. R., Cargnoni, A., Magatti, M., Parolini, O., & Silini, A. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00447 · Cited by 52
D’Orazi, G., Cordani, M., & Cirone, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03677-7 · Cited by 51
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
Masi, M., Racchi, M., Travelli, C., Corsini, E., & Buoso, E. (2021) · Cells · doi:10.3390/cells10112999 · Cited by 49
Roles of RNA-binding proteins in immune diseases and cancer
Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 49
A Comprehensive Update on the Bioactive Compounds from Seagrasses
Gono, C. M. P., Ahmadi, P., Hertiani, T., Septiana, E., Putra, M. Y., & Chianese, G. (2022) · Marine Drugs · doi:10.3390/md20070406 · Cited by 52
Ferroptosis interaction with inflammatory microenvironments: Mechanism, biology, and treatment
Dou, J., Liu, X., Yang, L., Huang, D., & Tan, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113711 · Cited by 52
Kopp, W. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1037750 · Cited by 60
Li, M., Jiang, P., Wei, S., Wang, J., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113312 · Cited by 52
Tumour extracellular vesicles induce neutrophil extracellular traps to promote lymph node metastasis
Su, X., Brassard, A., Bartolomucci, A., Dhoparee‐Doomah, I., Qiu, Q., Tsering, T., Rohanizadeh, R., Koufos, O., Giannias, B., Bourdeau, F., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12341 · Cited by 49
Horvat, N. K., Chocarro, S., Marques, O., Bauer, T. A., Qiu, R., Diaz-Jimenez, A., Helm, B., Chen, Y., Sawall, S., Sparla, R., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c08335 · Cited by 51
Exploration beyond osteoarthritis: the association and mechanism of its related comorbidities
Li, B., Yang, Z., Li, Y., Zhang, J., Li, C., & Lv, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1352671 · Cited by 55
Inflammation and cancer: friend or foe?
Smith, A. D. T., Córdoba-Hernandez, S., Mejía-Guarnizo, L. V., Monroy-Camacho, P. S., & Rodríguez-García, J. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1385479 · Cited by 53
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations
Ge, J., Yin, X., & Chen, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457189 · Cited by 52
Li, K., Chen, Y., Zhang, Z., Wang, K., Sulayman, S., Zeng, X., Ababaike, S., Guan, J., & Zhao, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-96592-5 · Cited by 49
Cheung, M. K., Yue, G. G., Chiu, P. W. Y., & Lau, C. B. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00744 · Cited by 49
Emerging Roles of Long non-coding RNAs in The Tumor Microenvironment
Zhou, L., Zhu, Y., Sun, D., & Zhang, Q. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.44420 · Cited by 49
Feng, Y., Zhang, N., Wang, S., Zou, W., He, Y., Ma, J., Liu, P., Liu, X., Hu, C., & Hou, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.575417 · Cited by 49
In silico approaches in carcinogenicity hazard assessment: Current status and future needs
Tice, R. R., Bassan, A., Amberg, A., Anger, L. T., Beal, M. A., Bellion, P., Benigni, R., Birmingham, J. M., Brigo, A., Bringezu, F., et al. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100191 · Cited by 50
Eosinophils and Lung Cancer: From Bench to Bedside
Sibille, A., Corhay, J.-L., Louis, R. E., Ninane, V., Jérusalem, G., & Duysinx, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095066 · Cited by 48
Cysteine cathepsins: A long and winding road towards clinics
Biasizzo, M., Javoršek, U., Vidak, E., Zarić, M., & Turk, B. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101150 · Cited by 50
Metformin inhibits neutrophil extracellular traps-promoted pancreatic carcinogenesis in obese mice
Wang, G., Gao, H., Dai, S., Li, M., Gao, Y., Yin, L., Zhang, K., Zhang, J., Jiang, K., Miao, Y., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216155 · Cited by 47
Bhuia, M. S., Chowdhury, R., Sonia, F. A., Kamli, H. M., Shaikh, A. A., El‐Nashar, H. A. S., El‐Shazly, M., & Islam, M. T. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300847 · Cited by 49
Metadata
- Authors
- Greten, F. R., & Grivennikov, S. I.
- Affiliations
- Goethe University Frankfurt (DE)
- Fox Chase Cancer Center (US)
- Corresponding author
- Greten, Florian R.
- Grivennikov, Sergei I.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 51
- Issue
- 1
- Pages
- 27-41
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC6831096
- OpenAlex
- W2959497269
- Cited by
- 3,806
- References
- 178
- Citations by year
- 2026: 457 · 2025: 640 · 2024: 753 · 2023: 715 · 2022: 664 · 2021: 397 · 2020: 163 · 2019: 16
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01CA227629, CA218133)
- Pew Scholar in Biomedical Sciences
- US-Israel BSF
- NIH (P30 CA-006927)
- Georg-Speyer-Haus
- LOEWE Center Frankfurt Cancer Institute (III L 5 - 519/03/03.001 - (0015), FOR2438: Gr1916/11-1, SFB 815, 1177, 1292)
- German Federal Ministry of Health
- Ministry of Higher Education, Research and the Arts of the State of Hessen
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor inflammation, tumor inflammatory microenvironment, carcinogenesis, tumor initiation, tumor progression, metastasis, tumor-stroma interactions, cellular plasticity, tissue homeostasis, tissue repair, cancer therapy
- MeSH terms
- Animals, Chronic Disease, Homeostasis, Humans, Infections, Inflammation, Neoplasms, Neovascularization, Pathologic, Wound Healing, Autoimmunity, Tumor Microenvironment, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review